Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph H Gleiter

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Analytical and Bioanalytical Chemistry|May 21, 2005
Mass spectrometric identification of modified urinary nucleosides used as potential biomedical markers by LC-ITMS couplingBernd Kammerer, Antje Frickenschmidt, Christa E Müller, et al.
Journal of Clinical Pharmacology|May 21, 2010
No dose adjustment on coadministration of the PDE4 inhibitor roflumilast with a weak CYP3A, CYP1A2, and CYP2C19 inhibitor: an investigation using cimetidineGabriele M Böhmer, Christoph H Gleiter, Klaus Mörike, et al.
International Journal of Molecular Sciences|February 22, 2014
Interplay between endothelin and erythropoietin in astroglia: the role in protection against hypoxiaRichard Schäfer, Lars Mueller, Reinhild Buecheler, et al.
European Journal of Clinical Pharmacology|May 15, 2010
Pharmacokinetics of natural mistletoe lectins after subcutaneous injectionRoman Huber, Jürgen Eisenbraun, Barbara Miletzki, et al.
Rejuvenation Research|April 8, 2010
Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer diseaseLusine Danielyan, Roman Klein, Leah R Hanson, et al.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|October 4, 2003
[Quality of antithrombotic therapy in patients with chronic atrial fibrillation: the AFib Trial]Reinhild Bücheler, Christoph Meisner, Klaus Mörike, et al.
BMJ (Clinical Research Ed.)|June 1, 2002
Off label prescribing to children in primary care in Germany: retrospective cohort studyReinhild Bücheler, Matthias Schwab, Klaus Mörike, et al.
The Lancet. Infectious Diseases|November 21, 2009
Pharmacogenetics of antimalarial drugs: effect on metabolism and transportReinhold Kerb, Richard Fux, Klaus Mörike, et al.
Journal of the American Society for Mass Spectrometry|July 29, 2008
Identification of urinary modified nucleosides and ribosylated metabolites in humans via combined ESI-FTICR MS and ESI-IT MS analysisDino Bullinger, Richard Fux, Graeme Nicholson, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 20, 2008
Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patientsAntje Frickenschmidt, Holger Frohlich, Dino Bullinger, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Analytical and Bioanalytical Chemistry|May 21, 2005
Mass spectrometric identification of modified urinary nucleosides used as potential biomedical markers by LC-ITMS couplingBernd Kammerer, Antje Frickenschmidt, Christa E Müller, et al.
Journal of Clinical Pharmacology|May 21, 2010
No dose adjustment on coadministration of the PDE4 inhibitor roflumilast with a weak CYP3A, CYP1A2, and CYP2C19 inhibitor: an investigation using cimetidineGabriele M Böhmer, Christoph H Gleiter, Klaus Mörike, et al.
International Journal of Molecular Sciences|February 22, 2014
Interplay between endothelin and erythropoietin in astroglia: the role in protection against hypoxiaRichard Schäfer, Lars Mueller, Reinhild Buecheler, et al.
European Journal of Clinical Pharmacology|May 15, 2010
Pharmacokinetics of natural mistletoe lectins after subcutaneous injectionRoman Huber, Jürgen Eisenbraun, Barbara Miletzki, et al.
Rejuvenation Research|April 8, 2010
Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer diseaseLusine Danielyan, Roman Klein, Leah R Hanson, et al.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|October 4, 2003
[Quality of antithrombotic therapy in patients with chronic atrial fibrillation: the AFib Trial]Reinhild Bücheler, Christoph Meisner, Klaus Mörike, et al.
BMJ (Clinical Research Ed.)|June 1, 2002
Off label prescribing to children in primary care in Germany: retrospective cohort studyReinhild Bücheler, Matthias Schwab, Klaus Mörike, et al.
The Lancet. Infectious Diseases|November 21, 2009
Pharmacogenetics of antimalarial drugs: effect on metabolism and transportReinhold Kerb, Richard Fux, Klaus Mörike, et al.
Journal of the American Society for Mass Spectrometry|July 29, 2008
Identification of urinary modified nucleosides and ribosylated metabolites in humans via combined ESI-FTICR MS and ESI-IT MS analysisDino Bullinger, Richard Fux, Graeme Nicholson, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 20, 2008
Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patientsAntje Frickenschmidt, Holger Frohlich, Dino Bullinger, et al.
Pageof 7